Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Adenocarcinoma 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma 1Leukemia 1HER2-positive Breast Cancer 1Cystic Fibrosis 1Breast Neoplasms 1

Interventions

Trastuzumab 4pyrotinib 2pertuzumab 2Docetaxel 2tucatinib 1trastuzumab deruxtecan 1atezolizumab 1Hospital Information Systems 1Electronic Health Records 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × HER2-positive Breast Cancer × Electronic Health Records × Clear all
NCT05769751 2023-08-16

A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer

Daiichi Sankyo

Completed
865 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡